Alva AS, Mangat PK, Garrett-Mayer E, Halabi S, et al. Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. J Clin Oncol 2021 Apr 12:JCO2002923. doi: 10.1200/JCO.20.02923.
PMID: 33844595